Cargando…

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy

p53 status is a key biomarker for a variety of cancer types. However, it remains controversial whether p53 is an effective biomarker in oral squamous cell carcinoma (OSCC), particularly with regard to its prognostic value for OSCC patients with combinational treatment. The aim of the current study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, LI, FUKUMOTO, MANABU, LIU, DUO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834308/ https://www.ncbi.nlm.nih.gov/pubmed/24260053 http://dx.doi.org/10.3892/ol.2013.1627

Ejemplares similares

P53 Immunoexpression in Laryngeal Squamous Cell Carcinoma
por: CERCELARU, LILIANA, et al.
Publicado: (2017)

P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma
por: Leyva-Huerta, Elba R., et al.
Publicado: (2012)

Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx
por: Biesaga, Beata, et al.
Publicado: (2022)

Immunoexpression of p53 mutant-type in Iranian patients with primary and recurrence oral squamous cell carcinoma
por: Daneste, Hossein, et al.
Publicado: (2022)

Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinoma
por: Chen, Lihong, et al.
Publicado: (2012)

Immunoexpression of p53 in histologically negative surgical margins adjacent to oral squamous cell carcinoma: A preliminary study
por: Kamat, Mamata S, et al.
Publicado: (2020)

Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy
por: Chang, Ji Hyun, et al.
Publicado: (2016)

EGFR Immunoexpression in Laryngeal Squamous Cell Carcinoma
por: CERCELARU, LILIANA, et al.
Publicado: (2017)

TWIST and p-Akt immunoexpression in normal oral epithelium oral dysplasia and in oral squamous cell carcinoma
por: de Freitas Silva, Brunno-Santos, et al.
Publicado: (2012)

Assessment of Bax and Bcl-2 Immunoexpression in Patients with Oral Lichen Planus and Oral Squamous Cell Carcinoma
por: Nafarzadeh, Shima, et al.
Publicado: (2013)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
por: Wu, Zhen-Jie, et al.
Publicado: (2018)

The Correlation of KRAS Gene Expression and P53 Immunoexpression in Colorectal Adenocarcinoma
por: Rachmawati, Meike, et al.
Publicado: (2019)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Immunoexpression of programmed cell death 4 protein in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma
por: Desai, Karishma M, et al.
Publicado: (2017)

Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy
por: Pereira, Cynthia Brito Lins, et al.
Publicado: (2013)

Immunoexpression Analysis and Prognostic Value of BLCAP in Breast Cancer
por: Gromova, Irina, et al.
Publicado: (2012)

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival
por: Nassif, Elise F., et al.
Publicado: (2021)

Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma
por: Zargaran, Massoumeh
Publicado: (2020)

Immunoexpression of proliferation and apoptosis markers in oral vascular anomalies
por: da Silva, Tiago João, et al.
Publicado: (2022)

Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis
por: Qi, Xue, et al.
Publicado: (2023)

The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma
por: Su, Xuan, et al.
Publicado: (2019)

Concomitant p53 and PTEN immunoexpression to predict the risk of malignancy in endometrial polyps
por: Abrão, Féres, et al.
Publicado: (2018)

The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma
por: Nichita, Mirela Marcela, et al.
Publicado: (2021)

Lactate Dehydrogenase B Is Associated with the Response to Neoadjuvant Chemotherapy in Oral Squamous Cell Carcinoma
por: Sun, Wenyi, et al.
Publicado: (2015)

Comparison of orosomucoid-1 immunoexpression and angiogenesis between oral squamous cell carcinoma cases with different histological grades
por: Sánchez-Romero, Celeste, et al.
Publicado: (2021)

Significant Prognostic Factors Influencing the Survival Difference of Oral Tongue Squamous Cell Carcinoma
por: Boonpoapichart, Sarinya, et al.
Publicado: (2021)

Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
por: Wu, Jia-Feng, et al.
Publicado: (2017)

The clinical significance of Notch1 immunoexpression in Caucasian patients with colorectal adenocarcinoma
por: Piecuch, Adam, et al.
Publicado: (2020)

Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population
por: Chaudhari, Narendra T, et al.
Publicado: (2016)

The stromal immunoexpression of CLIC4 may be related to the difference in the biological behavior between oral squamous cell carcinoma and oral verrucous carcinoma
por: Xerez, Mariana Carvalho, et al.
Publicado: (2023)

Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders
por: Sharma, Pooja, et al.
Publicado: (2021)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
por: Li, Hongtao, et al.
Publicado: (2013)

Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis
por: Guo, Yaru, et al.
Publicado: (2022)

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
por: Choi, Chel Hun, et al.
Publicado: (2008)

Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
por: Trejo-Becerril, Catalina, et al.
Publicado: (2005)

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
por: KAWAJIRI, HIDEMI, et al.
Publicado: (2014)

Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma
por: Zedan, Walid, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_trb4j1r4f79c61fe6jh7egon2i